<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-10T16:44:39+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2016-30-Jun-2019)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Reduce estimated incidence of TB all forms by 12% in the next three years compared to 2014; Reduce estimated incidence of TB BK+ by 12% in the next three years compared to 2014; Reduce mortality due to tuberculosis by 20% in the next three years compared to 2014. Objectives: Improve the success of treatment of patients with TB and MDR TB with patient-centered support; Reduce the burden of TB in people living with HIV and reduce the burden of HIV in people affected by TB; Strengthen early detection and diagnosis of TB and MDR TB focused on patient care; Strengthen technical program management of the NTP; Strengthen the information and reporting cases of TB system and vital records.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-07-01" />
    <activity-date type="2" iso-date="2016-07-01" />
    <activity-date type="3" iso-date="2019-06-30" />
    <activity-date type="4" iso-date="2019-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="100">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="bb065ae5-d9f1-485f-9d78-110f76beaa3f">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-08-29" />
      <value currency="USD" value-date="2016-08-29">452258.78</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c2599e10-a705-492c-934d-415aa0d3c192">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-01" />
      <value currency="USD" value-date="2016-09-01">427258.78</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="deae3756-3f8d-44a5-9b93-aa30648fddc3">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-01" />
      <value currency="USD" value-date="2016-09-01">10000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="34a55943-1a18-4725-883f-300cf9c7f2c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-09" />
      <value currency="USD" value-date="2016-09-09">1759328.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="71320cd7-3a71-4358-88c1-cd64bde7c064">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-09" />
      <value currency="USD" value-date="2016-09-09">-15000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="32e163ff-1fbc-442f-8c0b-770a68f1520e">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">494068.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd3fd16e-160a-4f5f-8130-198905df64d0">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">372997.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="49b5847d-d7cd-4f6d-9aa2-d447d72571d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-13" />
      <value currency="USD" value-date="2016-09-13">15000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0f430d06-719e-46df-a922-106b2ff6346f">
      <transaction-type code="7" />
      <transaction-date iso-date="2016-09-21" />
      <value currency="USD" value-date="2016-09-21">408381.13</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="299e194e-ce4f-4b01-a1f7-a1c78512bb29">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">-408381.13</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcb2b719-febd-439f-acd0-d178f32bf972">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">1773230.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ada82300-f42c-4037-a522-b4935ec6dcbd">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-09-30" />
      <value currency="USD" value-date="2016-09-30">-877263.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3f2316a9-33de-4064-b38a-57706d055fea">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-10-04" />
      <value currency="USD" value-date="2016-10-04">353862.90</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d8193220-15bb-4e98-9afe-faad85e7c84a">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-13" />
      <value currency="USD" value-date="2016-12-13">28520.54</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bf12a38e-4919-4908-ad65-e2910ede5f36">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-02-14" />
      <value currency="USD" value-date="2017-02-14">3708.01</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b63beae3-4cc0-4b5c-b0b9-113da5e92f82">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-06-28" />
      <value currency="USD" value-date="2017-06-28">93359.94</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cfdd5cc0-8554-4d79-a791-0071fbb20c05">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-21" />
      <value currency="USD" value-date="2017-07-21">2856.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7b29dfed-de54-4ab7-87cd-a36972bf0fc8">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-21" />
      <value currency="USD" value-date="2017-07-21">150000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7108689f-4532-4447-91e2-086080c006ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-09-26" />
      <value currency="USD" value-date="2017-09-26">89390.72</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="043c9cc2-6787-43fd-b217-034e83f6c35a">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-06" />
      <value currency="USD" value-date="2017-11-06">1065840.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f723d127-9986-4d95-9359-7e4d57d32098">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-11-06" />
      <value currency="USD" value-date="2017-11-06">-1051531.89</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2fdd45a9-ea27-4cca-bd8d-139695de1575">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="be78c2ad-1f5d-4aa3-a244-64b4ea6192eb">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4f41b5b6-cb1a-4403-bc27-fd0e89287f35">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-23" />
      <value currency="USD" value-date="2018-01-23">241782.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6e981cea-f941-4427-8fe0-4dbd47aad22c">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-03-22" />
      <value currency="USD" value-date="2018-03-22">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c1749bf6-0696-4d33-94be-c16b5bccc57c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-27" />
      <value currency="USD" value-date="2018-03-27">75276.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="212e8703-1cc6-447c-8c01-3718f825c63f">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-04-03" />
      <value currency="USD" value-date="2018-04-03">8872.39</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ccf9b7b0-d165-481d-97f8-b8bd0a866b0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-04" />
      <value currency="USD" value-date="2018-05-04">79829.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="69af57f0-f45d-47dc-92b3-c43c62a01938">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-07" />
      <value currency="USD" value-date="2018-08-07">106027.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a60306fa-f849-4afa-92f9-fbd78acb38f0">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">101809.95</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5ed704ca-314c-4ced-a5b8-835d3193349e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-14" />
      <value currency="USD" value-date="2018-08-14">4376.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6668eb66-22e0-49a7-9744-6415a368b4fe">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-09" />
      <value currency="USD" value-date="2018-10-09">248679.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ab6dfa7-783f-40c4-b66e-db3e3c95a6d8">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">51447.55</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8637e603-e727-4856-821e-995938aa4efb">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-10-19" />
      <value currency="USD" value-date="2018-10-19">17693.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c9fe52e5-1275-44ab-bd77-de57ad627d23">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-31" />
      <value currency="USD" value-date="2018-10-31">788221.59</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="afcd979a-8866-490a-b3d5-b10f802668d3">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-10-31" />
      <value currency="USD" value-date="2018-10-31">-130047.23</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e42a0589-64a1-43cd-ad72-3dbcfafa5d8f">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">41704.17</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="efdb1ad5-7f89-467c-8055-7e7ad8d8af25">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">172356.06</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c7495eea-1ee9-4d77-9f55-f1abcc02d85e">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-02" />
      <value currency="USD" value-date="2018-11-02">238577.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f8bf2ddd-fdae-456d-b5e0-817efd9ef662">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-11-13" />
      <value currency="USD" value-date="2018-11-13">335220.82</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="183be491-f270-4b6c-a50b-4802a332e195">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">-363.18</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c603e135-5dfb-45e0-ba87-6c36de168657">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">1547500.66</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5a576f43-1160-4be8-b177-c8647b711bb2">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">322264.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="35ad9d22-35ba-42f3-8a13-53ceccd1cba9">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-19" />
      <value currency="USD" value-date="2018-12-19">612769.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d4e3036-8b09-4c82-a253-8523828cf067">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25ac08e9-870c-43f7-b088-ff12f7c8095e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-01-22" />
      <value currency="USD" value-date="2019-01-22">4696.21</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4b7ab1ed-0c4d-4d39-ab03-e8283e10651a">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-02-01" />
      <value currency="USD" value-date="2019-02-01">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0adb1a5e-0ccd-4245-9ba1-5c99989a141f">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">17128.56</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ba788fe-5e4e-45ad-bdf8-cd5962781d9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">4028.88</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="939ba3d5-e691-4438-9f22-7eadbd70e779">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-28" />
      <value currency="USD" value-date="2019-03-28">78109.80</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b7531bd7-379f-4c59-8df8-559601d35b4a">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-01-10" />
      <value currency="USD" value-date="2020-01-10">20000.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1be7fa0e-a027-4f41-8e04-c2d0616651da">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-01-20" />
      <value currency="USD" value-date="2020-01-20">-20000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0e58b963-74fa-4bc3-ac68-d287ed212133">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-01" />
      <value currency="USD" value-date="2020-07-01">-488504.21</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="464c82f7-9fa2-4fa0-961a-bd6af28bc8f5">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-07-06" />
      <value currency="USD" value-date="2020-07-06">1740.56</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="efc2b8e8-c799-4f2f-a231-bd52f807962d">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-10" />
      <value currency="USD" value-date="2020-07-10">-1740.56</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cf6b1c6-71bc-4457-9979-0daf40939967">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-08-07" />
      <value currency="USD" value-date="2020-08-07">86350.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="98d44c4b-037a-4bda-8dce-f3fe5ff4dd48">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">-86350.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 40.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 68; Denominator: 172; Percentage: 39.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 34; Denominator: 185; Percentage: 18.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 42; Denominator: 185; Percentage: 22.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 79; Denominator: 185; Percentage: 42.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 75; Denominator: 185; Percentage: 40.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 105.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 42.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 60; Denominator: 68; Percentage: 88.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 30; Denominator: 79; Percentage: 38%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37; Denominator: 42; Percentage: 88.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 70; Denominator: 79; Percentage: 88.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 62; Denominator: 75; Percentage: 82.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 94.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 36.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" ascending="0" aggregation-status="0">
        <title>
          <narrative>Percentage of cases with RR-TB and/or MDR-TB started on treatment for MDR-TB who were lost to follow up during the first six months of treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2012" iso-date="2012-12-31" value="17.9">
          <comment>
            <narrative>Numerator: 7; Denominator: 39.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="16.7">
            <comment>
              <narrative>Numerator: 10; Denominator: 60.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="16.7">
            <comment>
              <narrative>Numerator: 5; Denominator: 30.</narrative>
            </comment>
          </target>
          <actual value="10">
            <comment>
              <narrative>Numerator: 3; Denominator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="15">
            <comment>
              <narrative>Numerator: 6; Denominator: 40.</narrative>
            </comment>
          </target>
          <actual value="3.2">
            <comment>
              <narrative>Numerator: 2; Denominator: 62.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="14.6">
            <comment>
              <narrative>Numerator: 6; Denominator: 41.</narrative>
            </comment>
          </target>
          <actual value="8.7">
            <comment>
              <narrative>Numerator: 2; Denominator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="11.3">
            <comment>
              <narrative>Numerator: 6; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="5.3">
            <comment>
              <narrative>Numerator: 2; Denominator: 38.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="11.3">
            <comment>
              <narrative>Numerator: 6; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="8.3">
            <comment>
              <narrative>Numerator: 3; Denominator: 36.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="16.3">
          <comment>
            <narrative>Numerator: 38; Denominator: 233.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="35.1">
            <comment>
              <narrative>Numerator: 94; Denominator: 268.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="16.4">
            <comment>
              <narrative>Numerator: 47; Denominator: 287.</narrative>
            </comment>
          </target>
          <actual value="9.1">
            <comment>
              <narrative>Numerator: 26; Denominator: 287.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="45.6">
            <comment>
              <narrative>Numerator: 131; Denominator: 287.</narrative>
            </comment>
          </target>
          <actual value="43.6">
            <comment>
              <narrative>Numerator: 75; Denominator: 172.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="25.8">
            <comment>
              <narrative>Numerator: 84; Denominator: 326.</narrative>
            </comment>
          </target>
          <actual value="65.2">
            <comment>
              <narrative>Numerator: 73; Denominator: 112.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="63.5">
            <comment>
              <narrative>Numerator: 207; Denominator: 326.</narrative>
            </comment>
          </target>
          <actual value="65.3">
            <comment>
              <narrative>Numerator: 130; Denominator: 199.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="37.6">
            <comment>
              <narrative>Numerator: 131; Denominator: 348.</narrative>
            </comment>
          </target>
          <actual value="28.9">
            <comment>
              <narrative>Numerator: 77; Denominator: 266.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/high risk groups</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 97.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 180; Denominator: 18058; Percentage: 1%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 90; Denominator: 18058; Percentage: 0.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 84; Denominator: 22680; Percentage: 0.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 190; Denominator: 18058; Percentage: 1.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 163; Denominator: 23016; Percentage: 0.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 100.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 150.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 110.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 843.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1814; Denominator: 8246; Percentage: 22%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 907; Denominator: 9217; Percentage: 9.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 357; Denominator: 9217; Percentage: 3.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2537; Denominator: 9217; Percentage: 27.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 868; Denominator: 9217; Percentage: 9.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2340.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 523.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4681.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 985.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1436.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 500.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 3224.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4230; Denominator: 9400; Percentage: 45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2115; Denominator: 9450; Percentage: 22.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1564; Denominator: 9450; Percentage: 16.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4727; Denominator: 9450; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3311; Denominator: 9450; Percentage: 35%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1750.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1869; Percentage: 107%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3500.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3526.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1784.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1888.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of bacteriologically confirmed TB, new and relapses</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 2094.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2748; Denominator: 6110; Percentage: 45%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1375; Denominator: 6142; Percentage: 22.4%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1194; Denominator: 6142; Percentage: 19.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3073; Denominator: 6142; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2721; Denominator: 6142; Percentage: 44.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1469.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1393.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2700.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2635.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1391.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1495.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="86.6">
          <comment>
            <narrative>Numerator: 1813; Denominator: 2093.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="87" />
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 1958; Denominator: 2254.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 2403; Denominator: 2700.</narrative>
            </comment>
          </target>
          <actual value="86.7">
            <comment>
              <narrative>Numerator: 1985; Denominator: 2290.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 2475; Denominator: 2782.</narrative>
            </comment>
          </target>
          <actual value="86.8">
            <comment>
              <narrative>Numerator: 2201; Denominator: 2536.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="69.1">
          <comment>
            <narrative>Numerator: 199; Denominator: 288.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="79.9">
            <comment>
              <narrative>Numerator: 230; Denominator: 288.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="84.7">
            <comment>
              <narrative>Numerator: 244; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="67.7">
            <comment>
              <narrative>Numerator: 193; Denominator: 285.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="94.8">
            <comment>
              <narrative>Numerator: 273; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 252; Denominator: 290.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="85.6">
          <comment>
            <narrative>Numerator: 2766; Denominator: 3231.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="86" />
          <actual value="87.5">
            <comment>
              <narrative>Numerator: 2809; Denominator: 3210.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3080; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 2684; Denominator: 3076.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 3175; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="87.4">
            <comment>
              <narrative>Numerator: 2704; Denominator: 3094.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="92.7">
          <comment>
            <narrative>Numerator: 228; Denominator: 246.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="93.3">
            <comment>
              <narrative>Numerator: 250; Denominator: 268.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 126; Denominator: 280.</narrative>
            </comment>
          </target>
          <actual value="22.1">
            <comment>
              <narrative>Numerator: 62; Denominator: 280.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="94.3">
            <comment>
              <narrative>Numerator: 264; Denominator: 280.</narrative>
            </comment>
          </target>
          <actual value="54.1">
            <comment>
              <narrative>Numerator: 131; Denominator: 242.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="45.6">
            <comment>
              <narrative>Numerator: 139; Denominator: 305.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="95.4">
            <comment>
              <narrative>Numerator: 291; Denominator: 305.</narrative>
            </comment>
          </target>
          <actual value="78">
            <comment>
              <narrative>Numerator: 206; Denominator: 264.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="48.1">
            <comment>
              <narrative>Numerator: 153; Denominator: 318.</narrative>
            </comment>
          </target>
          <actual value="40.4">
            <comment>
              <narrative>Numerator: 203; Denominator: 502.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients who had an HIV test result recorded in the TB register</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="30">
          <comment>
            <narrative>Numerator: 2790; Denominator: 9300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3722; Denominator: 4230.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="39.4">
            <comment>
              <narrative>Numerator: 1861; Denominator: 4727.</narrative>
            </comment>
          </target>
          <actual value="94">
            <comment>
              <narrative>Numerator: 1470; Denominator: 1564.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="89.1">
            <comment>
              <narrative>Numerator: 4211; Denominator: 4727.</narrative>
            </comment>
          </target>
          <actual value="96">
            <comment>
              <narrative>Numerator: 3178; Denominator: 3311.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="46.5">
            <comment>
              <narrative>Numerator: 1628; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="99.5">
            <comment>
              <narrative>Numerator: 1859; Denominator: 1869.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 3255; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="99.3">
            <comment>
              <narrative>Numerator: 3502; Denominator: 3526.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="47">
            <comment>
              <narrative>Numerator: 1676.49; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="48.5">
            <comment>
              <narrative>Numerator: 1832; Denominator: 3776.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="13.2">
          <comment>
            <narrative>Numerator: 316; Denominator: 2385.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-07-01" />
          <period-end iso-date="2016-12-31" />
          <target value="21.2">
            <comment>
              <narrative>Numerator: 720; Denominator: 3400.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-06-30" />
          <target value="14.7">
            <comment>
              <narrative>Numerator: 360; Denominator: 2450.</narrative>
            </comment>
          </target>
          <actual value="34.2">
            <comment>
              <narrative>Numerator: 839; Denominator: 2450.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-07-01" />
          <period-end iso-date="2017-12-31" />
          <target value="35.1">
            <comment>
              <narrative>Numerator: 860; Denominator: 2450.</narrative>
            </comment>
          </target>
          <actual value="24.6">
            <comment>
              <narrative>Numerator: 860; Denominator: 3501.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-06-30" />
          <target value="19.6">
            <comment>
              <narrative>Numerator: 500; Denominator: 2550.</narrative>
            </comment>
          </target>
          <actual value="12.7">
            <comment>
              <narrative>Numerator: 203; Denominator: 1598.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-07-01" />
          <period-end iso-date="2018-12-31" />
          <target value="45.1">
            <comment>
              <narrative>Numerator: 1150; Denominator: 2550.</narrative>
            </comment>
          </target>
          <actual value="17.5">
            <comment>
              <narrative>Numerator: 350; Denominator: 2005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-06-30" />
          <target value="25">
            <comment>
              <narrative>Numerator: 650; Denominator: 2600.</narrative>
            </comment>
          </target>
          <actual value="8">
            <comment>
              <narrative>Numerator: 223; Denominator: 2780.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2019-30-Jun-2022)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: To reduce the prevalence, incidence, mortality and human suffering due to tuberculosis in the country, strengthening comprehensive and integrated care services for promotion, prevention and care, with a person, family and community centered approach. Objectives: Strengthen early detection, diagnosis and treatment of drug-sensitive TB, especially in high-risk groups; Strengthen early detection, diagnosis and treatment of DR-TB, especially in high-risk groups; Reduce the burden of TB for PLHIV and HIV on people affected by TB; Strengthen the commitment of communities, civil society organizations and all public and private health care providers; Strengthen the system for information and notification of cases of TB and vital records (mortality due to TB).</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-07-01" />
    <activity-date type="2" iso-date="2019-07-01" />
    <activity-date type="3" iso-date="2022-06-30" />
    <activity-date type="4" iso-date="2022-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="67.45">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="32.55">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.06">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="12.25">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2e778829-d9f6-4382-b52a-31c55a719622" percentage="9.54">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Other program management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="79f56a06-e483-471f-ad35-812bf3014339" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Administrative and finance data sources</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.29">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="043741b4-bd0a-492c-8759-b4cac0a50e64" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Other health information systems and M&amp;E intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="2.45">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="41f514b1-2e70-4f77-98c1-68e6052dc6a9" percentage="1.61">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="5.39">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="14.45">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a4cf383e-48f0-4449-bdfd-4fefcc86f8e3" percentage="0.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8bfd5db3-426b-4dc3-aec1-929f85b850a4" percentage="1.88">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Other MDR-TB intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="30.77">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="cbff055b-fbc0-468b-9604-e69b10cbd9dd" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="1a563d22-2c21-4f9a-b142-805695850ac9" percentage="1.91">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="56afe3f2-1fa3-4fd3-b845-9ea07f4bfd51" percentage="10.62">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="1.54">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0da342b5-b462-4465-bf9a-1fdb9d39596f" percentage="1.37">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Removing human rights and gender related barriers to TB care and prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="1.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="0.92">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">682442.69</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">1879953.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">2018990.04</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1268096.08</value>
    </budget>
    <capital-spend percentage="40.72" />
    <transaction ref="05f6ef3e-2022-487b-a2ce-682292b373f3">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-07-12" />
      <value currency="USD" value-date="2019-07-12">3663724.42</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7180ce6d-5da0-461d-93ea-0fa1ede7754d">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-16" />
      <value currency="USD" value-date="2019-07-16">199690.42</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ac3fa46-18f4-4e95-aa30-f123f088de5d">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-07" />
      <value currency="USD" value-date="2019-08-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="85a00344-e4fe-493f-b10e-e458fbed0997">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-11" />
      <value currency="USD" value-date="2019-10-11">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="489c6424-eb4f-48f8-9d4d-f753192b6434">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-22" />
      <value currency="USD" value-date="2019-10-22">102987.94</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0de546b0-86e4-403d-83ad-ee484bcfc0d3">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-19" />
      <value currency="USD" value-date="2019-11-19">130989.19</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="808cc4c6-c2a4-4b6f-b073-c826ae292796">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-30" />
      <value currency="USD" value-date="2020-01-30">146212.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="424e0298-e907-44fe-98c5-0b42a2e689f1">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-13" />
      <value currency="USD" value-date="2020-02-13">124840.07</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0142a9e0-c89a-4e4a-bbdc-5b1f35c19ce4">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">15285.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e5f3cef4-40ea-443b-8b5a-d408f52b7390">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">25774.37</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="549b7727-8862-47d7-a042-05d0e71598ea">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-03-12" />
      <value currency="USD" value-date="2020-03-12">20000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb731c96-dab2-422d-bb18-73d8f4f13d9d">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-23" />
      <value currency="USD" value-date="2020-04-23">306946.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="85d42c69-6ddc-4b31-9c4b-d2cc9365f306">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-08" />
      <value currency="USD" value-date="2020-05-08">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a19a0b8-2e75-4968-9fee-d03d98fc147f">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">32070.67</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="050fe890-13d4-4882-8543-cd7b0987b3a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-12" />
      <value currency="USD" value-date="2020-08-12">1209367.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cbb4e74d-5bb4-4ac1-9d92-627412d22166">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-08-26" />
      <value currency="USD" value-date="2020-08-26">51894.04</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3caf901e-8c28-4b93-ac2e-122d279d5aef">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-03" />
      <value currency="USD" value-date="2020-12-03">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ad12681a-5787-4782-b397-eea2efb28812">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">15465.73</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="af6bb425-b8dc-4b98-9bdd-63070bdd3808">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-17" />
      <value currency="USD" value-date="2020-12-17">1812465.85</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1b74e499-00bd-4585-bfe8-7640747a512b">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-17" />
      <value currency="USD" value-date="2020-12-17">-1282201.99</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c7b8c09-7957-474f-91c8-296d931f28c6">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-20" />
      <value currency="USD" value-date="2021-01-20">12700.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0c4b8c1-8a1e-4bfe-912c-a20ef6c31cc5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-28" />
      <value currency="USD" value-date="2021-01-28">142722.76</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6dc5dad-dfc3-47f7-9ba2-cb2f56724e80">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">19875.44</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d0c38f0-ae03-41a8-9860-ad9a8e4dac42">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-01" />
      <value currency="USD" value-date="2021-07-01">31635.96</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e46ff82-0233-452e-b5d4-22fcf63b36a4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-07" />
      <value currency="USD" value-date="2021-07-07">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ac1f0ef4-d1ba-4c43-9b3b-02904451d4a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-15" />
      <value currency="USD" value-date="2021-07-15">6101.68</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="600e54f2-db51-41e0-8265-7a8fc6ce0470">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-02" />
      <value currency="USD" value-date="2021-09-02">12700.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd980e9d-a828-4570-95ba-ecd0147f4ae8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-08" />
      <value currency="USD" value-date="2021-09-08">67833.60</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2e065367-9bc1-49ec-9a36-818c58504dfb">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-01" />
      <value currency="USD" value-date="2021-10-01">18451.37</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5a3602bb-b8cc-47dc-a50f-7476cc5aecf3">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-18451.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="345566bc-38d8-47c5-b573-dd777eb5491f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">119658.66</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="682b84df-61dd-4aa7-86f4-00c88ea4fcbe">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-01" />
      <value currency="USD" value-date="2021-11-01">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dc94ea92-8a59-4ba0-b69b-43ebf7aa30e9">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-02" />
      <value currency="USD" value-date="2021-11-02">1565496.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0480923-c4a0-48ae-aea0-8d54a06ea6f4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-02" />
      <value currency="USD" value-date="2021-11-02">-1399237.75</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8ae556d-3388-4ae1-8e53-15a36afdf3fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">48127.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="25315ac5-a7d7-4170-a22b-67582fb06fdb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">18961.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e86add85-caba-490d-95a2-d5db6f71c3c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">549497.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d4b03be5-68a8-43a4-bb8a-85db5922fbff">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-18" />
      <value currency="USD" value-date="2021-11-18">24315.10</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4746579c-c64d-4f42-a681-9847358c3243">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-01-27" />
      <value currency="USD" value-date="2022-01-27">38220.63</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c798e8a4-8820-4ee0-ae9e-db1e12af5a27">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">46437.37</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7216933-9e92-42cc-9449-4dac868feba3">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">79118.16</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8c354e2d-4b68-491a-968d-59cdf31730aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-03" />
      <value currency="USD" value-date="2022-02-03">496170.26</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="32d944a9-900c-4ab8-92b9-2d015be17ae8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-02-25" />
      <value currency="USD" value-date="2022-02-25">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5bd3145-ac3d-4842-90af-d7033cc04dd2">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-24" />
      <value currency="USD" value-date="2022-03-24">168586.31</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc578909-f179-4cba-826a-165e6ebce1fd">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-04-04" />
      <value currency="USD" value-date="2022-04-04">3971.05</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d9b8d159-a80b-4987-a16a-1f3c3a706326">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-04-08" />
      <value currency="USD" value-date="2022-04-08">-3971.05</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b33f5477-da2e-4a77-bb8f-a2bf3711525b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-04-28" />
      <value currency="USD" value-date="2022-04-28">9325.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8ac5e31c-60e4-44d2-b42c-ffdc5190d8d7">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-17" />
      <value currency="USD" value-date="2022-05-17">-86738.17</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="43604e81-0a44-482e-bc7b-04cac20f1c7b">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-05-17" />
      <value currency="USD" value-date="2022-05-17">367404.82</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d995d26a-dd3e-449f-bffd-c925dd10ee1b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">58055.95</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bcc5d04e-5fad-465a-81e0-af10673cc57e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">246593.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="644fa30a-886a-419a-a51b-497d1ad11898">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">62755.87</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0b7e59f9-85ea-4790-8fa6-e9ce35c1765a">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-06-01" />
      <value currency="USD" value-date="2022-06-01">5031.24</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b5a6eb0-b141-4807-b55e-182e20491efb">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-02" />
      <value currency="USD" value-date="2022-06-02">-5031.24</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="151b40aa-d072-4c8d-8163-6bf17c3f841a">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-16" />
      <value currency="USD" value-date="2022-06-16">279139.92</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1da388fa-7e69-4af5-8a60-c3bf3c448251">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-06-23" />
      <value currency="USD" value-date="2022-06-23">279139.92</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2a24aa13-4d47-4727-8b93-7f9202fbe90d">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-10-01" />
      <value currency="USD" value-date="2022-10-01">6002.26</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bc432f3a-2074-403a-baf3-7350a339a618">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-19" />
      <value currency="USD" value-date="2022-10-19">-6002.26</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7091ec6-2567-4b45-9b7e-4a0f8215c24a">
      <transaction-type code="7" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">23470.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="17d82c6b-f0e5-484e-b1ee-ac0636ed5029">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-12-15" />
      <value currency="USD" value-date="2022-12-15">-23470.38</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="48d29d01-8dd1-4e4a-aa56-5967b5f7dfae">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-23" />
      <value currency="USD" value-date="2023-02-23">-25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20200630">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-06-30" />
      <value currency="USD" value-date="2020-06-30">605631.95</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2019 to Jun 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20210630">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-06-30" />
      <value currency="USD" value-date="2021-06-30">1593550.70</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2020 to Jun 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20220630">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-06-30" />
      <value currency="USD" value-date="2022-06-30">2346981.59</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2021 to Jun 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP02-EXP-20221230">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-30" />
      <value currency="USD" value-date="2022-12-30">290188.29</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP02, Jul 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 75.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 75; Percentage: 1.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 74; Denominator: 75; Percentage: 98.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 41; Denominator: 75; Percentage: 54.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 34; Denominator: 75; Percentage: 45.33%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 51; Denominator: 53; Percentage: 96.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 53; Percentage: 1.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 17; Denominator: 53; Percentage: 32.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 35; Denominator: 53; Percentage: 66%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 38.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 37; Denominator: 38; Percentage: 97.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 38; Percentage: 2.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 38; Percentage: 28.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 27; Denominator: 38; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 41.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 40; Denominator: 41; Percentage: 97.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 41; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 17; Denominator: 41; Percentage: 41.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 24; Denominator: 41; Percentage: 58.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 29; Denominator: 33; Percentage: 87.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 33; Percentage: 6.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 16; Denominator: 33; Percentage: 48.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17; Denominator: 33; Percentage: 51.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 88.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 73.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 31; Denominator: 33; Percentage: 93.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 33; Percentage: 6.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 33; Percentage: 33.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 22; Denominator: 33; Percentage: 66.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 39; Denominator: 40; Percentage: 97.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 40; Percentage: 2.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 40; Percentage: 35%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 26; Denominator: 40; Percentage: 65%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 62.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 62; Denominator: 62; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 62; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 62; Percentage: 40.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 37; Denominator: 62; Percentage: 108.06%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 42; Denominator: 43; Percentage: 97.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 43; Percentage: 2.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 43; Percentage: 32.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 29; Denominator: 43; Percentage: 67.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25; Denominator: 26; Percentage: 96.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 26; Percentage: 3.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9; Denominator: 26; Percentage: 34.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 17; Denominator: 26; Percentage: 65.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 34; Denominator: 34; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 34; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 14; Denominator: 34; Percentage: 41.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 34; Percentage: 58.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 42.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 21.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 19; Denominator: 21; Percentage: 90.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 21; Percentage: 9.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 21; Percentage: 52.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 10; Denominator: 21; Percentage: 47.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 28; Denominator: 30; Percentage: 93.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2; Denominator: 30; Percentage: 6.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 10; Denominator: 30; Percentage: 33.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 30; Percentage: 66.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 88.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 31; Denominator: 32; Percentage: 96.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 32; Percentage: 3.12%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12; Denominator: 32; Percentage: 37.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 20; Denominator: 32; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="30.07">
          <comment>
            <narrative>Numerator: 1036; Denominator: 3445.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="35">
            <comment>
              <narrative>Numerator: 624; Denominator: 1783.</narrative>
            </comment>
          </target>
          <actual value="61">
            <comment>
              <narrative>Numerator: 1075; Denominator: 1763.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="40.01">
            <comment>
              <narrative>Numerator: 743; Denominator: 1857.</narrative>
            </comment>
          </target>
          <actual value="66.2">
            <comment>
              <narrative>Numerator: 959; Denominator: 1449.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="60">
            <comment>
              <narrative>Numerator: 2229; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="64">
            <comment>
              <narrative>Numerator: 1745; Denominator: 2725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="64.97">
            <comment>
              <narrative>Numerator: 1228; Denominator: 1890.</narrative>
            </comment>
          </target>
          <actual value="76.2">
            <comment>
              <narrative>Numerator: 1153; Denominator: 1513.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 2457; Denominator: 3780.</narrative>
            </comment>
          </target>
          <actual value="71.7">
            <comment>
              <narrative>Numerator: 2156; Denominator: 3005.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="66.7">
            <comment>
              <narrative>Numerator: 3802; Denominator: 5702.</narrative>
            </comment>
          </target>
          <actual value="73.8">
            <comment>
              <narrative>Numerator: 3672; Denominator: 4978.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="69.98">
            <comment>
              <narrative>Numerator: 1345; Denominator: 1922.</narrative>
            </comment>
          </target>
          <actual value="76.8">
            <comment>
              <narrative>Numerator: 1516; Denominator: 1973.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among key affected populations/ high risk groups (other than prisoners)</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 1708.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
          <comment>
            <narrative>Numerator: 18; Denominator: 2017; Percentage: 0.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Target / Risk population group" value="Others" />
          <comment>
            <narrative>Numerator: 1465; Denominator: 2017; Percentage: 72.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 840.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 830.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1791; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 830; Denominator: 1791; Percentage: 46.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 955.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 716.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1449; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 716; Denominator: 1449; Percentage: 49.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 956.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 620.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 2; Denominator: 1253; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 618; Denominator: 1253; Percentage: 49.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 967.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 750.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 4; Denominator: 1494; Percentage: 0.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 746; Denominator: 1494; Percentage: 49.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 968.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 768.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 8; Denominator: 1500; Percentage: 0.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 760; Denominator: 1500; Percentage: 50.67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1947.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1791.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 979.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1023.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Migrants/ refugees/ IDPs" />
            <comment>
              <narrative>Numerator: 4; Denominator: 1973; Percentage: 0.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Target / Risk population group" value="Others" />
            <comment>
              <narrative>Numerator: 1019; Denominator: 1973; Percentage: 51.65%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="163" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="150" />
          <actual value="132" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="163" />
          <actual value="132" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="163" />
          <actual value="109" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="173" />
          <actual value="124" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="173" />
          <actual value="126" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="356" />
          <actual value="253" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="183" />
          <actual value="127" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="885" />
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="535" />
          <actual value="389" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="650" />
          <actual value="223" />
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="650" />
          <actual value="276" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="756" />
          <actual value="299" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="1603" />
          <actual value="567" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="756" />
          <actual value="248" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="847" />
          <actual value="319" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 3445.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3097; Denominator: 3445; Percentage: 10.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 348; Denominator: 3445; Percentage: 89.7%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2826; Denominator: 3445; Percentage: 81.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1492; Denominator: 3445; Percentage: 7.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1953; Denominator: 3445; Percentage: 3.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 3064; Denominator: 3445; Percentage: 43.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 130; Denominator: 3445; Percentage: 56.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 251; Denominator: 3445; Percentage: 88.93%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1784.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1763.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1547; Denominator: 1763; Percentage: 87.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 210; Denominator: 1763; Percentage: 11.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1428; Denominator: 1763; Percentage: 81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 690; Denominator: 1763; Percentage: 39.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1073; Denominator: 1763; Percentage: 60.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1457; Denominator: 1763; Percentage: 82.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 172; Denominator: 1763; Percentage: 9.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 136; Denominator: 1763; Percentage: 7.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1857.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1449.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1306; Denominator: 1449; Percentage: 90.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 133; Denominator: 1449; Percentage: 9.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1167; Denominator: 1449; Percentage: 80.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 554; Denominator: 1449; Percentage: 38.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 893; Denominator: 1449; Percentage: 61.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1245; Denominator: 1449; Percentage: 85.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 107; Denominator: 1449; Percentage: 7.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 97; Denominator: 1449; Percentage: 6.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1858.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1253.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1128; Denominator: 1253; Percentage: 90%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 118; Denominator: 1253; Percentage: 9.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 987; Denominator: 1253; Percentage: 78.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 518; Denominator: 1253; Percentage: 41.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 735; Denominator: 1253; Percentage: 58.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1125; Denominator: 1253; Percentage: 89.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 36; Denominator: 1253; Percentage: 2.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 92; Denominator: 1253; Percentage: 7.3%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1494.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1328; Denominator: 1494; Percentage: 88.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 164; Denominator: 1494; Percentage: 11%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1182; Denominator: 1494; Percentage: 79.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 608; Denominator: 1494; Percentage: 40.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 886; Denominator: 1494; Percentage: 59.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1370; Denominator: 1494; Percentage: 91.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 22; Denominator: 1494; Percentage: 1.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 102; Denominator: 1494; Percentage: 6.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1890.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1500.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1342; Denominator: 1500; Percentage: 89.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 158; Denominator: 1500; Percentage: 10.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1161; Denominator: 1500; Percentage: 77.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 608; Denominator: 1500; Percentage: 40.53%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 892; Denominator: 1500; Percentage: 59.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1317; Denominator: 1500; Percentage: 87.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 35; Denominator: 1500; Percentage: 2.33%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 148; Denominator: 1500; Percentage: 9.87%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3812.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3473.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1922.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1973.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1766; Denominator: 1973; Percentage: 89.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 207; Denominator: 1973; Percentage: 10.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1618; Denominator: 1973; Percentage: 82.01%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 801; Denominator: 1973; Percentage: 40.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1172; Denominator: 1973; Percentage: 59.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1766; Denominator: 1973; Percentage: 89.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 33; Denominator: 1973; Percentage: 1.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 174; Denominator: 1973; Percentage: 8.82%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="87.26">
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="95">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="95">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 2684; Denominator: 3076.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="72">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 204; Denominator: 214.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="72">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 204; Denominator: 214.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="87.78">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 2470; Denominator: 2814.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <baseline year="2016" iso-date="2016-12-31" value="71.76">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 122; Denominator: 170.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="88.86">
            <comment>
              <narrative>Numerator: 3110; Denominator: 3500.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 2991; Denominator: 3385.</narrative>
            </comment>
          </actual>
          <actual value="87.6">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2621; Denominator: 2993.</narrative>
            </comment>
          </actual>
          <actual value="94.4">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 370; Denominator: 392.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="89.01">
            <comment>
              <narrative>Numerator: 3175; Denominator: 3567.</narrative>
            </comment>
          </target>
          <actual value="87.6">
            <comment>
              <narrative>Numerator: 3144; Denominator: 3591.</narrative>
            </comment>
          </actual>
          <actual value="89.6">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 3219; Denominator: 3591.</narrative>
            </comment>
          </actual>
          <actual value="8.9">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 320; Denominator: 3591.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="89.91">
            <comment>
              <narrative>Numerator: 3340; Denominator: 3715.</narrative>
            </comment>
          </target>
          <actual value="89.2">
            <comment>
              <narrative>Numerator: 2275; Denominator: 2551.</narrative>
            </comment>
          </actual>
          <actual value="93.53">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2386; Denominator: 2551.</narrative>
            </comment>
          </actual>
          <actual value="6.19">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 158; Denominator: 2551.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="76.25">
          <comment>
            <narrative>Numerator: 183; Denominator: 240.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target value="87.05">
            <comment>
              <narrative>Numerator: 121; Denominator: 139.</narrative>
            </comment>
          </target>
          <actual value="71.6">
            <comment>
              <narrative>Numerator: 96; Denominator: 134.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target value="90.28">
            <comment>
              <narrative>Numerator: 130; Denominator: 144.</narrative>
            </comment>
          </target>
          <actual value="80.4">
            <comment>
              <narrative>Numerator: 78; Denominator: 97.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target value="90.28">
            <comment>
              <narrative>Numerator: 260; Denominator: 288.</narrative>
            </comment>
          </target>
          <actual value="97.8">
            <comment>
              <narrative>Numerator: 90; Denominator: 92.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90.13">
            <comment>
              <narrative>Numerator: 137; Denominator: 152.</narrative>
            </comment>
          </target>
          <actual value="55.8">
            <comment>
              <narrative>Numerator: 58; Denominator: 104.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90.2">
            <comment>
              <narrative>Numerator: 424; Denominator: 470.</narrative>
            </comment>
          </target>
          <actual value="83">
            <comment>
              <narrative>Numerator: 357; Denominator: 430.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90.13">
            <comment>
              <narrative>Numerator: 274; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="82.8">
            <comment>
              <narrative>Numerator: 212; Denominator: 256.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90.36">
            <comment>
              <narrative>Numerator: 150; Denominator: 166.</narrative>
            </comment>
          </target>
          <actual value="83.3">
            <comment>
              <narrative>Numerator: 145; Denominator: 174.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31">
          <comment>
            <narrative>Numerator: 973; Denominator: 3501; Percentage: 27.79%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-07-01" />
          <period-end iso-date="2019-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 750; Denominator: 2499; Percentage: 30.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 419; Denominator: 2749; Percentage: 15.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 966; Denominator: 2762; Percentage: 34.97%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 118; Denominator: 607; Percentage: 19.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-07-01" />
          <period-end iso-date="2020-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1933; Denominator: 5525; Percentage: 34.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 273; Denominator: 1624; Percentage: 16.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1215; Denominator: 3038; Percentage: 39.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2430; Denominator: 6077; Percentage: 39.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 628; Denominator: 1971; Percentage: 31.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3934; Denominator: 9419; Percentage: 41.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1022; Denominator: 2998; Percentage: 34.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1504; Denominator: 3342; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 394; Denominator: 1027; Percentage: 38.4%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Strengthen DOTS Strategy within the Framework of the New Strategy: Stop TB - Guatemala (01-Jul-2022-30-Jun-2025)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reducir la prevalencia, incidencia y mortalidad por tuberculosis en todas sus formas en el país.// Reduce the prevalence, incidence and mortality of all forms of tuberculosis in the country. Objectives: Fortalecer la detección y diagnóstico precoz de la TB y TB-FR, sobretodo en grupos de alto riesgo por medio de uso de pruebas moleculares y otros medios de diagnostico rapidos. //Strengthen the early detection and diagnosis of TB and DR-TB, especially in high-risk groups through the use of molecular tests and other means of rapid diagnosis; Mejorar el éxito de tratamiento de las personas con TB y TB-FR, con el soporte centrado en el paciente. // Improve treatment success for people with TB and DR-TB, with patient-centered support; Disminuir la carga de tuberculosis entre personas que viven con VIH y de VIH en afectados con tuberculosis.// Reduce the burden of tuberculosis among people living with HIV and HIV among those affected with tuberculosis; Mejorar el cumplimiento de las actividades preventivas contra la TB. // Improve compliance of TB prevention activities.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-07-01" />
    <activity-date type="2" iso-date="2022-07-01" />
    <activity-date type="3" iso-date="2025-06-30" />
    <activity-date type="4" iso-date="2025-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="79.28">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="20.72">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="5.9">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="6.64">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="e61e1ae8-85c6-488f-8a92-215981bf93a2" percentage="2.54">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="3.79">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="1.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.66">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="1.78">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="22851d66-f7e4-4cc5-950a-ad9cac3568a2" percentage="4.1">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Community MDR-TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="0.29">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="3.15">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="40.03">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.96">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.95">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="70cce1e1-1248-426c-b949-2fe2feec2c0a" percentage="0.82">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key Populations (TB care and prevention) - Children</narrative>
        </description>
      </budget-item>
      <budget-item code="a87c4f51-0287-43c7-9064-8f92833da8c6" percentage="0.13">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Mobile populations: refugees, migrants and internally displaced people</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="8.19">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="6.94">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="8.51">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="2.66">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2146ce4f-9254-4a2a-8be8-e14734ab53dc" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">1889656.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">1591901.96</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">739023.52</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">166530.31</value>
    </budget>
    <capital-spend percentage="35.18" />
    <transaction ref="32d50bfe-38ef-480f-aa6d-0b8256a2b22f">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-06-27" />
      <value currency="USD" value-date="2022-06-27">3431559.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c598524f-8be0-4554-a9e9-f1400214c664">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-01" />
      <value currency="USD" value-date="2022-07-01">366882.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b558fc27-fbe5-4b94-8722-8be4d8d8991f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">57878.40</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f28510a-68f8-4612-9924-59b3d39ccdce">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">6364.29</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4aa70557-6476-47ab-aea1-d5d5862d10b9">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-22" />
      <value currency="USD" value-date="2022-11-22">112506.22</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="841427a1-e903-4360-b7b9-0fd90c937174">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">904839.64</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="445b9476-12dd-4c6d-898d-07f012bfb1c9">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-16" />
      <value currency="USD" value-date="2023-02-16">57370.81</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac3db986-8194-42aa-86c4-5f426ecdde2f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-02-21" />
      <value currency="USD" value-date="2023-02-21">6175.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bb972b79-d59f-4e55-b1ec-bda9ca511b19">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-03-09" />
      <value currency="USD" value-date="2023-03-09">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4d1d45b6-3577-49d0-b158-49e7e60424cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-03-21" />
      <value currency="USD" value-date="2023-03-21">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eb0f5aff-e675-4ed1-abf8-99bded2f8662">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">4287.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e91da67-0346-4717-88d8-97377d6ba208">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-07-01" />
      <value currency="USD" value-date="2023-07-01">3812.61</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="86f10fc7-3628-4bbc-a946-67c33e2932dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-11" />
      <value currency="USD" value-date="2023-07-11">9325.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9104d8bc-0a3a-49c3-a42b-453bfcf43102">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-12" />
      <value currency="USD" value-date="2023-07-12">-3812.61</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4b8f407e-6bf0-4f00-abdd-5504bd7d3b14">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-18" />
      <value currency="USD" value-date="2023-07-18">51870.98</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="50fa027a-84a2-4fbd-9b55-b943e4121a6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-07-23" />
      <value currency="USD" value-date="2023-07-23">25000.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ad51737c-0426-4b22-b8f6-960bd2ed912d">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-08-31" />
      <value currency="USD" value-date="2023-08-31">25000.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="063b5c9c-46ed-40c3-9999-f8aeeab8d1c8">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">9072.68</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="08ca18d9-32fc-4a54-af6c-7aafc2ad7e81">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">39151.04</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="18aa0e8b-4dbc-4961-aae7-b5497dc8060b">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-12" />
      <value currency="USD" value-date="2023-09-12">7332.82</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c17cb1a6-581f-4fdd-b586-af0eb1cd4674">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">-9072.68</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c5223e3-17ec-403a-b20a-855268e64737">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-05" />
      <value currency="USD" value-date="2023-10-05">90700.48</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="443523fa-dbee-4238-8389-ca6d1246dd19">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-12-04" />
      <value currency="USD" value-date="2023-12-04">1041.30</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4257b6df-2451-4da5-978a-bbad48d03ba6">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">-1041.30</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="beff3039-d1a5-40eb-bcd6-2786dd04b9fd">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-26" />
      <value currency="USD" value-date="2024-02-26">1784217.80</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3c3e0f4-9470-46b1-9c16-63ede3305b12">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-02-26" />
      <value currency="USD" value-date="2024-02-26">-1716874.28</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3ede97f6-1970-48e7-8065-bad050305df8">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-03-01" />
      <value currency="USD" value-date="2024-03-01">635400.80</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c96c62a2-3ab0-419e-8cd3-134fff837815">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-12" />
      <value currency="USD" value-date="2024-04-12">11018.38</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d997a2ef-28b8-4ab5-a5d7-0b468ece1b36">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-26" />
      <value currency="USD" value-date="2024-04-26">-11018.38</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5197a40c-8532-4e67-8b30-bec5a9b05600">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-07-01" />
      <value currency="USD" value-date="2024-07-01">3031.41</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c8f9d47e-88c5-4757-8702-e5b641ac0734">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-05" />
      <value currency="USD" value-date="2024-07-05">-3031.41</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ddaaad1e-15b2-404c-85cb-87e2d220f730">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-06" />
      <value currency="USD" value-date="2024-08-06">137698.20</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="be93a829-aca6-4aae-a713-d43a694b49a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-08-20" />
      <value currency="USD" value-date="2024-08-20">89632.66</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c0e547a4-6987-4b1a-9b33-53bcf288aa6c">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-09-01" />
      <value currency="USD" value-date="2024-09-01">4154.74</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce57fb6d-f533-4a03-a3f1-944f73dc1333">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-10" />
      <value currency="USD" value-date="2024-09-10">24619.97</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e580805a-2076-42f2-95f9-21c059a72c08">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-10" />
      <value currency="USD" value-date="2024-09-10">490260.52</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="191e5eff-46af-4333-8858-cee5e3a8523b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-4154.74</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cff2a94-9fba-4764-b6a7-157d9699fe47">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-09-30" />
      <value currency="USD" value-date="2024-09-30">-6615.04</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3bff1c2d-e120-4d27-8191-7c9ad498b8c4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-10-01" />
      <value currency="USD" value-date="2024-10-01">6615.04</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="df395c4c-5d83-40a5-90dd-548e7d358d56">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-11-19" />
      <value currency="USD" value-date="2024-11-19">202398.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0a8d88c3-6c01-4091-b526-c8389a021928">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">769963.24</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="27aab0f5-5133-4619-960c-46ec1691b6cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-02-04" />
      <value currency="USD" value-date="2025-02-04">-204207.29</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="73ed9294-04dc-4b12-817d-07e3232ba8b3">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-27" />
      <value currency="USD" value-date="2025-02-27">532121.87</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="03029b9c-e38f-4e13-bb31-f4e85539ef81">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-03-07" />
      <value currency="USD" value-date="2025-03-07">103.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="87975067-a823-41ea-bd83-737168ab95bc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-03-26" />
      <value currency="USD" value-date="2025-03-26">-103.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="729394d2-9906-4764-a144-28981c9822fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-08" />
      <value currency="USD" value-date="2025-05-08">204451.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7860197b-8454-4ed2-bac3-77b085128f4c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-08" />
      <value currency="USD" value-date="2025-05-08">-237841.37</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e2eeebd3-f275-4ba7-aba8-15a3251a240f">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-13" />
      <value currency="USD" value-date="2025-05-13">55394.28</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ca66782c-8fcf-43a5-99d6-c03fc5bd5471">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-05" />
      <value currency="USD" value-date="2025-06-05">5663.99</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="39bc5a57-555f-4c31-9c0c-0a1724d93cc0">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-11" />
      <value currency="USD" value-date="2025-06-11">15100.86</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7ef4f791-a2c0-494d-86dc-916b57edd8b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-13" />
      <value currency="USD" value-date="2025-06-13">-5663.99</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8cec00a9-ba67-48c7-bc52-0fc0bc8c7cce">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-01" />
      <value currency="USD" value-date="2025-09-01">1553.02</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b97511f9-6d54-4cab-9038-9f5ddb6542b6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-15" />
      <value currency="USD" value-date="2025-09-15">-1553.02</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8851a830-385c-4ce1-a491-13600bebea7c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-03-09" />
      <value currency="USD" value-date="2026-03-09">1294.44</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7b9de10-67b9-413a-b69c-e4bca2fa67fc">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-03-17" />
      <value currency="USD" value-date="2026-03-17">-1294.44</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4c83803c-9699-4f3f-84d8-8d145d541b2c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-05-28" />
      <value currency="USD" value-date="2026-05-28">-133956.23</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="93fdbb2b-1b94-4208-88ac-9d0413c6497e">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from GTM-T-MSPASP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="307eab11-804c-40d6-b8f3-8a1f091accc2">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">-225054.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20230630">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-06-30" />
      <value currency="USD" value-date="2023-06-30">899600.51</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2022 to Jun 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">927421.08</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2023 to Jun 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20250630">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">1957002.00</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2024 to Jun 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP03-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">2983.04</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP03, Jul 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2021/Tuberculosis/en/GTM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - Tuberculosis - Guatemala - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1045-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2021/Tuberculosis/es/GTM-T_FundingRequest_1_es.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - Tuberculosis - Guatemala - Español</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1045-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="es" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 103.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 103; Percentage: 0.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 103; Percentage: 0.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 102; Denominator: 103; Percentage: 99.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 102; Denominator: 103; Percentage: 99.03%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 65; Denominator: 103; Percentage: 63.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 65; Denominator: 103; Percentage: 63.11%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 38; Denominator: 103; Percentage: 36.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 38; Denominator: 103; Percentage: 36.89%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 27; Denominator: 27; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 27; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 11; Denominator: 27; Percentage: 40.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 16; Denominator: 27; Percentage: 59.26%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 111.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 67.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 40.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 56.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 64.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 59.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 120.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 76.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 61.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 32.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 86.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 86; Percentage: 1.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1; Denominator: 86; Percentage: 1.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 85; Denominator: 86; Percentage: 98.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 85; Denominator: 86; Percentage: 98.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0; Denominator: 86; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 0; Denominator: 86; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 77; Denominator: 86; Percentage: 89.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 77; Denominator: 86; Percentage: 89.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 34; Denominator: 86; Percentage: 39.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 34; Denominator: 86; Percentage: 39.53%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 51; Denominator: 86; Percentage: 59.3%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 51; Denominator: 86; Percentage: 59.3%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 24.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 24; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 9; Denominator: 24; Percentage: 37.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 15; Denominator: 24; Percentage: 62.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 24; Denominator: 24; Percentage: 100%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 50.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 108.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 53.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 55.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 57.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 115.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 70.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 58.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 29.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 22.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 31.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 17.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="243" />
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="279" />
          <actual value="293" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="134" />
          <actual value="162" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="145" />
          <actual value="131" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="146" />
          <actual value="184" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="303" />
          <actual value="329" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="157" />
          <actual value="145" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="158" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="327" />
          <actual value="367" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="169" />
          <actual value="181" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 3762.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 442; Denominator: 3762; Percentage: 11.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 442; Denominator: 3762; Percentage: 11.75%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3256; Denominator: 3762; Percentage: 86.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 3256; Denominator: 3762; Percentage: 86.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2248; Denominator: 3762; Percentage: 59.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 2248; Denominator: 3762; Percentage: 59.76%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 224; Denominator: 3762; Percentage: 5.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 224; Denominator: 3762; Percentage: 5.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2985; Denominator: 3762; Percentage: 79.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2985; Denominator: 3762; Percentage: 79.35%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 401; Denominator: 3762; Percentage: 10.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 401; Denominator: 3762; Percentage: 10.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1514; Denominator: 3762; Percentage: 40.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 1514; Denominator: 3762; Percentage: 40.24%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 3762; Percentage: 83.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 3137; Denominator: 3762; Percentage: 83.39%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3945.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4350.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1942.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2055.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1825; Denominator: 2055; Percentage: 88.81%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 218; Denominator: 2055; Percentage: 10.61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1715; Denominator: 2055; Percentage: 83.45%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 846; Denominator: 2055; Percentage: 41.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1209; Denominator: 2055; Percentage: 58.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 1860; Denominator: 2055; Percentage: 90.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 48; Denominator: 2055; Percentage: 2.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 147; Denominator: 2055; Percentage: 7.15%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2003.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2295.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2003.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2275.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4073.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4620.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2070.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4209.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4508.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2071.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2138.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2297.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2141.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 156.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 1952.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 975.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1322.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 2065.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 46.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 186.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 1078.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 13; Denominator: 1078; Percentage: 1.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 13; Denominator: 1078; Percentage: 1.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 145; Denominator: 1078; Percentage: 13.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="5-14" />
          <comment>
            <narrative>Numerator: 145; Denominator: 1078; Percentage: 13.45%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 908; Denominator: 1078; Percentage: 84.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 908; Denominator: 1078; Percentage: 84.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 990.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1057.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 127; Denominator: 1057; Percentage: 12.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 541; Denominator: 1057; Percentage: 51.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 375; Denominator: 1057; Percentage: 35.48%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2352.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2134.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1362.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3121.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1911.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1362.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 834.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 1759.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 3941.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2631.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 1760.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2181.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1492.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="5-14" />
            <comment>
              <narrative>Numerator: 514.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 392.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="84.58">
          <comment>
            <narrative>Numerator: 3144; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="86.6">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3219; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="1.4">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 52; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="34.49">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 1282; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="72.82">
          <dimension name="HIV test status" value="Not documented" />
          <comment>
            <narrative>Numerator: 2309; Denominator: 3171.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31" value="8.61">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 320; Denominator: 3717.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3418; Denominator: 3884.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 2532; Denominator: 2937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 3418; Denominator: 3884.</narrative>
            </comment>
          </target>
          <actual value="86.2">
            <comment>
              <narrative>Numerator: 2532; Denominator: 2937.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3605; Denominator: 4006.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 3502; Denominator: 4032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="89.99">
            <comment>
              <narrative>Numerator: 3605; Denominator: 4006.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 3502; Denominator: 4032.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 3726; Denominator: 4141.</narrative>
            </comment>
          </target>
          <actual value="84.72">
            <comment>
              <narrative>Numerator: 3858; Denominator: 4554.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89.98">
            <comment>
              <narrative>Numerator: 3726; Denominator: 4141.</narrative>
            </comment>
          </target>
          <actual value="84.72">
            <comment>
              <narrative>Numerator: 3858; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="40.01">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1822; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="59.99">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 2732; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="90.01">
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 4099; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="2">
            <dimension name="HIV test status" value="Not documented" />
            <comment>
              <narrative>Numerator: 91; Denominator: 4554.</narrative>
            </comment>
          </actual>
          <actual value="7.99">
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 364; Denominator: 4554.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="85.85">
          <comment>
            <narrative>Numerator: 358; Denominator: 417.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="87.27">
            <comment>
              <narrative>Numerator: 192; Denominator: 220.</narrative>
            </comment>
          </target>
          <actual value="77.6">
            <comment>
              <narrative>Numerator: 114; Denominator: 147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2023-06-30" />
          <target value="88.9">
            <comment>
              <narrative>Numerator: 400; Denominator: 450.</narrative>
            </comment>
          </target>
          <actual value="88.3">
            <comment>
              <narrative>Numerator: 272; Denominator: 308.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90.43">
            <comment>
              <narrative>Numerator: 208; Denominator: 230.</narrative>
            </comment>
          </target>
          <actual value="98.1">
            <comment>
              <narrative>Numerator: 158; Denominator: 161.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-06-30" />
          <target value="91.9">
            <comment>
              <narrative>Numerator: 432; Denominator: 470.</narrative>
            </comment>
          </target>
          <actual value="77.4">
            <comment>
              <narrative>Numerator: 312; Denominator: 403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90.87">
            <comment>
              <narrative>Numerator: 209; Denominator: 230.</narrative>
            </comment>
          </target>
          <actual value="82.7">
            <comment>
              <narrative>Numerator: 158; Denominator: 191.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="92.92">
            <comment>
              <narrative>Numerator: 223; Denominator: 240.</narrative>
            </comment>
          </target>
          <actual value="72.6">
            <comment>
              <narrative>Numerator: 154; Denominator: 212.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2025-06-30" />
          <target value="93.5">
            <comment>
              <narrative>Numerator: 460; Denominator: 492.</narrative>
            </comment>
          </target>
          <actual value="72.89">
            <comment>
              <narrative>Numerator: 277; Denominator: 380.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="92.92">
            <comment>
              <narrative>Numerator: 223; Denominator: 240.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="94.05">
            <comment>
              <narrative>Numerator: 237; Denominator: 252.</narrative>
            </comment>
          </target>
          <actual value="80.11">
            <comment>
              <narrative>Numerator: 149; Denominator: 186.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-10T16:44:39+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-GTM-T-MSPAS-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>To reduce tuberculosis prevalence, incidence, and mortality by strengthening integrated care of promotion, prevention and cure services, with a focus on the person, family and community; with support of multisectors and civil society - Guatemala (01-Jul-2025-30-Jun-2028)</narrative>
    </title>
    <description type="1">
      <narrative>Guatemala, Tuberculosis, Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </description>
    <description type="2">
      <narrative>Goal: Reducir la prevalencia, incidencia, mortalidad y el sufrimiento humano por tuberculosis en el país, fortaleciendo la atención integrada de servicios de promoción, prevención y curación, con enfoque centrado en la persona, la familia y la comunidad;  contando con el apoyo e involucramiento multisectorial y de la sociedad civil. / Reduce the prevalence, incidence, mortality and human suffering due to tuberculosis in the country, strengthening integrated care of promotion, prevention and cure services, with a focus on the person, family and community; with the support and involvement of multisectors and civil society. Objectives: Fortalecer la prevención y atención integrada e integral de la tuberculosis centrada en la persona, familia, comunidad y su entorno, principalmente en grupos de alto riesgo. / Strengthen integrated and comprehensive prevention and care of tuberculosis focused on the person, family, community and their environment, mainly in high-risk groups; Fortalecer el compromiso de las comunidades, las organizaciones de la sociedad civil y todos los proveedores de atención públicos y privados para el control de la TB / Strengthen the commitment of communities, civil society organizations and all public and private care providers for TB control; Mejorar la calidad y oportunidad del sistema de información y notificación de casos de TB y mortalidad por TB, / Improve the quality and timeliness of the information and notification system for TB cases and TB mortality,.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
    </participating-org>
    <other-identifier ref="GTM-T-MSPASP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-07-01" />
    <activity-date type="2" iso-date="2025-07-01" />
    <activity-date type="3" iso-date="2028-06-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Serena Buccini</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>serena.buccini@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="GT" percentage="100">
      <narrative>Guatemala</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="62.74">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="37.26">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.56">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="10.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="09d00f5e-f29a-445c-a7e5-4a1e21a3dce7" percentage="2.68">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory-based surveillance</narrative>
        </description>
      </budget-item>
      <budget-item code="19ae85a9-12db-4fb8-9313-84f9feef29a0" percentage="3.52">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="2.83">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="4.32">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="1.52">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="2.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="6.71">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1a5ab4c7-9695-4567-adb4-0a3768fa01ee" percentage="1.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.97">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="3.83">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="4.81">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="99700b2a-3a9a-4855-b789-986d7a150e52" percentage="0.6">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Children and adolescents</narrative>
        </description>
      </budget-item>
      <budget-item code="1ed5e501-534e-43ae-bb9f-9552bd6bf461" percentage="0.19">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Mobile population (migrants/refugees/IDPs)</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="18.48">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="2.77">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="5.24">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="23.15">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="1.31">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="8f363382-1b81-4d2d-a396-2be1435016f2" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.77">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">1389690.78</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">1266717.05</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">494224.26</value>
    </budget>
    <capital-spend percentage="24.12" />
    <transaction ref="69b2f6f4-c494-498b-bd3e-c139a3e81b9c">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-29" />
      <value currency="USD" value-date="2025-09-29">1301443.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f4e2b07a-46bb-4203-9671-e44790b3ce63">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">677993.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="04ec60e5-7836-4d8a-8ba7-95addce9037a">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-14" />
      <value currency="USD" value-date="2026-04-14">67352.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e152f6f8-82c0-4301-9c56-48f0731afb29">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">36149.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e6294659-9c2f-4b73-adef-f825f2f35b3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-28" />
      <value currency="USD" value-date="2026-04-28">31203.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e00e7d41-6099-4c06-b812-d87797210ce2">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">93247.23</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cb526fdf-23c5-43d5-a818-29288944ca85">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">16197.36</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8dc49ee-b3ee-4fc8-ac70-e12385b749bb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-21" />
      <value currency="USD" value-date="2026-07-21">30114.20</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b4fb25db-29c6-4f57-a3a1-e501042e0efb">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">4564.83</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="875b2ec8-3acc-423c-afe6-a7e450234854">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-08" />
      <value currency="USD" value-date="2026-09-08">174878.46</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="250e68bf-ef87-4ac0-9333-02c1184701b5">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Global Fund disbursement to GTM-T-MSPASP04 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5c7c8a0d-cd79-4cdf-baad-707e5261d651">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-10-09" />
      <value currency="USD" value-date="2026-10-09">225054.00</value>
      <description>
        <narrative>Global Fund commitment to GTM-T-MSPASP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="GTM-T-MSPASP04-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">81558.13</value>
      <description>
        <narrative>Expenditure reported by Ministry of Health and Social Assistance of the Republic of Guatemala for GTM-T-MSPASP04, Jul 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="10">
        <narrative>Ministry of Health and Social Assistance of the Republic of Guatemala</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/GTM-T-MSPAS" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-10" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2024/Tuberculosis/en/GTM-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - Tuberculosis - Guatemala - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1666-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/GTM/2024/Tuberculosis/es/GTM-T_FundingRequest_1_es.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - Tuberculosis - Guatemala - Español</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1666-GTM-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="es" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 73.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 66; Denominator: 76; Percentage: 86.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 10; Denominator: 76; Percentage: 13.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 33; Denominator: 76; Percentage: 43.42%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 41; Denominator: 76; Percentage: 53.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 63; Denominator: 76; Percentage: 82.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7; Denominator: 76; Percentage: 9.21%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 7; Denominator: 76; Percentage: 9.21%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 45.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 48.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 26.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 106.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 62; Denominator: 73; Percentage: 84.93%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 54; Denominator: 64; Percentage: 84.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 10; Denominator: 64; Percentage: 15.63%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 29; Denominator: 64; Percentage: 45.31%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 2; Denominator: 64; Percentage: 3.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 35; Denominator: 64; Percentage: 54.69%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 58; Denominator: 64; Percentage: 90.63%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 87.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 86.67%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 87.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 28; Denominator: 28; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 25; Denominator: 25; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 12; Denominator: 28; Percentage: 42.86%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 1.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 16; Denominator: 28; Percentage: 57.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 27.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 90.74%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 65; Denominator: 66; Percentage: 98.48%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1; Denominator: 66; Percentage: 1.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 25; Denominator: 66; Percentage: 37.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 3; Denominator: 66; Percentage: 4.55%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 41; Denominator: 66; Percentage: 62.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 58; Denominator: 66; Percentage: 87.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 7; Denominator: 66; Percentage: 10.61%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 0; Denominator: 66; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 66; Denominator: 66; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 62; Denominator: 66; Percentage: 93.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 1; Denominator: 66; Percentage: 1.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 46; Denominator: 66; Percentage: 69.7%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 46; Denominator: 68; Percentage: 67.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 43; Denominator: 65; Percentage: 66.15%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 3; Denominator: 3; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 18; Denominator: 68; Percentage: 26.47%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 16.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 28; Denominator: 68; Percentage: 41.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 44; Denominator: 68; Percentage: 64.71%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 2; Denominator: 68; Percentage: 2.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0; Denominator: 68; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 68; Denominator: 68; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 68; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 80%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 85%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among key affected populations/high risk groups (other than prisoners); *includes only those with new and relapse</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="1875" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="985" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="965.5" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="985" />
          <actual value="1297" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="1921" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="1830" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="95.45">
          <comment>
            <narrative>Numerator: 21; Denominator: 22.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="96">
            <comment>
              <narrative>Numerator: 24; Denominator: 25.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="96.88">
            <comment>
              <narrative>Numerator: 31; Denominator: 32.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of community organizations that received a pre-defined package of training</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of community organizations that received a pre-defined package of training</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="4" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="20" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="12" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="20" />
          <actual value="35" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="64" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="99" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="0">
          <comment>
            <narrative>Numerator: 0; Denominator: 29.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="13.79">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="13.8">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="13.79">
            <comment>
              <narrative>Numerator: 4; Denominator: 29.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 29.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="41.38">
            <comment>
              <narrative>Numerator: 12; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="68.97">
            <comment>
              <narrative>Numerator: 20; Denominator: 29.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 4617.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3940; Denominator: 4617; Percentage: 85.34%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 677; Denominator: 4617; Percentage: 14.66%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 3758; Denominator: 4617; Percentage: 81.39%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1818; Denominator: 4617; Percentage: 39.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2799; Denominator: 4617; Percentage: 60.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 4157; Denominator: 4617; Percentage: 90.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 353; Denominator: 4617; Percentage: 7.65%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 107; Denominator: 4617; Percentage: 2.32%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 2423.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2471.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2471.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2563.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2406.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 157.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 2200.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 950.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1613.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 2308.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 211.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 44.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4943.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4703.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 3073; Denominator: 4617; Percentage: 66.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Private" />
          <comment>
            <narrative>Numerator: 3063; Denominator: 3073; Percentage: 99.67%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 10; Denominator: 3073; Percentage: 0.33%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 71%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1671; Denominator: 2563; Percentage: 65.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Private" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 84.2%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target>
            <comment>
              <narrative>Percentage: 85.01%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="86.86">
          <comment>
            <narrative>Numerator: 3502; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="85.54">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3449; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="14.46">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 583; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="40.28">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1624; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="59.72">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2408; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="88.59">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 3572; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="7.59">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 306; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31" value="3.82">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 154; Denominator: 4032.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="88" />
          <actual value="84.47">
            <comment>
              <narrative>Numerator: 2758; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="82.77">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 2388; Denominator: 2885.</narrative>
            </comment>
          </actual>
          <actual value="97.37">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 370; Denominator: 380.</narrative>
            </comment>
          </actual>
          <actual value="33.14">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 1082; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="51.33">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1676; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 0; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="8.24">
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 269; Denominator: 3265.</narrative>
            </comment>
          </actual>
          <actual value="0">
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 0; Denominator: 3265.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="90" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="90" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="883" />
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="550" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2026-06-30" />
          <target value="747" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="747" />
          <actual value="2164" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2027-06-30" />
          <target value="1635" />
        </period>
        <period>
          <period-start iso-date="2027-07-01" />
          <period-end iso-date="2028-06-30" />
          <target value="1899" />
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>